APA (7th ed.) Citation

J, G., X, M., IP, K., A, N., S, M., E, H., . . . P, C. (2026). Single-cell transcriptomics reveals FXR1 as an actionable target for siRNA therapy in ovarian cancer. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-71468-y

Chicago Style (17th ed.) Citation

J, George, et al. "Single-cell Transcriptomics Reveals FXR1 as an Actionable Target for SiRNA Therapy in Ovarian Cancer." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-71468-y.

MLA (9th ed.) Citation

J, George, et al. "Single-cell Transcriptomics Reveals FXR1 as an Actionable Target for SiRNA Therapy in Ovarian Cancer." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-71468-y.